ACRX Description — Talphera Inc
AcelRx Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Co.'s portfolio consists of nafamostat product candidates and pre-filled syringe product candidates. Co.'s nafamostat product candidates include Niyad, which is being developed as a regional anticoagulant for injection into the extracorporeal circuit; and LTX-608, which is Co.'s proprietary nafamostat formulation for direct IV infusion. Co.'s pre-filled syringe product candidates include Fedsyra, which is an ephedrine pre-filled syringe; and the phenylephrine pre-filled syringe.